NewLimit
Backed by
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
Senior Research Associate, Immunology
Senior Research Associate, PK/PD Assays
Data Scientist
Computational Biologist
Director, Operations
Senior/Research Associate
Scientist/Senior Scientist, Immunology
Scientist/Senior Scientist
Senior Research Associate, Metabolism
Senior/Research Associate, Drug Product Development
Senior/Research Associate, Functional Genomics
Head of Translation
Explore similar companies to NewLimit
Candid Health
Easy, automated medical billing.
Biotech · Series C · Onsite · Based in San Francisco
Latent Labs
Making biology programmable.
Biotech · Series A · Remote · Based in London
Invert
Modern software for bioprocess data.
Biotech · Seed · Remote · Based in San Francisco
Sway
Seaweed as replacement for plastic.
Biotech · Seed · Remote · Based in San Francisco
Colossal
The de-extinction company.
Biotech · Series C · Remote · Based in Dallas
Salt
AI for life sciences.
Biotech · Series A · Remote · Based in Los Angeles
Until
Developing reversible cryopreservation.
Biotech · Series A · Onsite · Based in San Francisco
Nudge
Whole-brain interfaces for everyday life.
Biotech · Series A · Onsite · Based in San Francisco
Valthos
Next-generation biodefense.
Biotech · Seed · Onsite · Based in New York
Industries
Investors
Cities